Overview This page contains the latest trade data of Heterocyclic compounds: lactams: clobazam (INN) and methyprylon (INN). In 2023, Heterocyclic compounds: lactams: clobazam (INN) and methyprylon (INN) were the world's 4752nd most traded product, with a total trade of $13.1M. Between 2022 and 2023 the exports of Heterocyclic compounds: lactams: clobazam (INN) and methyprylon (INN) grew by 11.4%, from $11.8M to $13.1M. Trade in Heterocyclic compounds: lactams: clobazam (INN) and methyprylon (INN) represent 0.000058% of total world trade.
Heterocyclic compounds: lactams: clobazam (INN) and methyprylon (INN) are a part of Heterocyclic compounds with nitrogen hetero-atom(s) only.
Exports In 2023 the top exporters of Heterocyclic compounds: lactams: clobazam (INN) and methyprylon (INN) were France ($5.43M), Germany ($4.29M), India ($2.26M), Italy ($602k), and Netherlands ($255k).
Imports In 2023 the top importers of Heterocyclic compounds: lactams: clobazam (INN) and methyprylon (INN) were Brazil ($2.6M), France ($2.43M), India ($2.07M), United States ($814k), and Japan ($677k).
Ranking Heterocyclic compounds: lactams: clobazam (INN) and methyprylon (INN) ranks 758th in the Product Complexity Index (PCI).